Total Payments
$3,368
2023 Payments
$47.35
Companies
26
Transactions
150
Medicare Patients
1,030
Medicare Billing
$68,024
Payment Breakdown by Category
Food & Beverage$3,368 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,368 | 150 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $525.18 | 28 | $0 (2022) |
| ABBVIE INC. | $377.61 | 23 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $269.28 | 14 | $0 (2022) |
| Amarin Pharma Inc. | $252.99 | 14 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $214.59 | 7 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $206.67 | 4 | $0 (2021) |
| Corcept Therapeutics | $198.38 | 5 | $0 (2022) |
| Althera Pharmaceuticals LLC | $159.61 | 4 | $0 (2022) |
| GlaxoSmithKline, LLC. | $158.11 | 2 | $0 (2021) |
| SI-BONE, INC. | $146.08 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $47.35 | 2 | ABBVIE INC. ($47.35) |
| 2022 | $1,216 | 55 | Janssen Pharmaceuticals, Inc ($256.38) |
| 2021 | $2,105 | 93 | Novo Nordisk Inc ($365.06) |
All Payment Transactions
150 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/03/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $30.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/24/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/16/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Neuroscience | ||||||
| 06/07/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/13/2022 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 05/11/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Gastroenterology | ||||||
| 05/10/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/05/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Cardiovascular | ||||||
| 05/03/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/28/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: VACCINE | ||||||
| 04/27/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: NEUROSCIENCE | ||||||
| 04/26/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/25/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/21/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/20/2022 | Althera Pharmaceuticals LLC | Roszet (Drug) | Food and Beverage | In-kind items and services | $122.87 | General |
| Category: Cardiovascular | ||||||
| 04/20/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Gastroenterology | ||||||
| 04/19/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Diabetes | ||||||
| 04/18/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Cardiovascular | ||||||
| 04/15/2022 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Neurology | ||||||
| 04/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.64 | General |
| 04/13/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Cardiovascular | ||||||
| 04/13/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 04/12/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/12/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/08/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 292 | 318 | $77,081 | $17,352 |
| 2022 | 9 | 464 | 556 | $113,408 | $27,956 |
| 2021 | 6 | 274 | 350 | $69,668 | $22,715 |
Total Patients
1,030
Total Services
1,224
Medicare Billing
$68,024
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 64 | $20,480 | $5,287 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 81 | $17,820 | $4,155 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $12,558 | $2,590 | 20.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 50 | 51 | $10,404 | $2,433 | 23.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $11,846 | $2,057 | 17.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 12 | 12 | $1,848 | $394.11 | 21.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 17 | 17 | $850.00 | $275.40 | 32.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 15 | $1,110 | $109.80 | 9.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 15 | $165.00 | $51.15 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 118 | 144 | $38,622 | $9,251 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 143 | $28,593 | $7,231 | 25.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 50 | 50 | $15,800 | $3,480 | 22.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $13,172 | $3,261 | 24.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 65 | 74 | $11,396 | $3,058 | 26.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 25 | 52 | $2,600 | $844.08 | 32.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 11 | 11 | $1,694 | $553.60 | 32.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 17 | $1,138 | $150.70 | 13.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 32 | 37 | $393.00 | $126.94 | 32.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 143 | $36,322 | $11,242 | 31.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 95 | 114 | $19,722 | $6,192 | 31.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 23 | 23 | $7,475 | $3,202 | 42.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 16 | 16 | $4,384 | $1,754 | 40.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 21 | 25 | $1,475 | $225.12 | 15.3% |
| 81002 | Urinalysis, manual test | Office | 2021 | 27 | 29 | $290.00 | $100.92 | 34.8% |
About Lace Busby
Lace Busby is a Family healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/01/2020. The National Provider Identifier (NPI) number assigned to this provider is 1720685993.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lace Busby has received a total of $3,368 in payments from pharmaceutical and medical device companies, with $47.35 received in 2023. These payments were reported across 150 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,368).
As a Medicare-enrolled provider, Busby has provided services to 1,030 Medicare beneficiaries, totaling 1,224 services with total Medicare billing of $68,024. Data is available for 3 years (2021–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location San Antonio, TX
- Active Since 10/01/2020
- Last Updated 10/01/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1720685993
Products in Payments
- VRAYLAR (Drug) $290.22
- Vascepa (Drug) $252.99
- XARELTO (Drug) $236.79
- Ozempic (Drug) $228.81
- NURTEC ODT (Drug) $206.67
- Korlym (Drug) $198.38
- BREZTRI (Drug) $171.53
- Roszet (Drug) $159.61
- Rybelsus (Drug) $146.81
- IFUSE IMPLANT (Device) $146.08
- RYBELSUS (Drug) $136.25
- GARDASIL 9 (Biological) $132.34
- TRELEGY ELLIPTA (Drug) $124.99
- NEXLETOL (Drug) $122.27
- ADUHELM (Biological) $98.38
- TRINTELLIX (Drug) $71.49
- JARDIANCE (Drug) $67.27
- Kerendia (Drug) $61.99
- MYRBETRIQ (Drug) $52.40
- XIFAXAN (Drug) $43.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in San Antonio
Mrs. Anna Castro, Fnp, FNP
Family — Payments: $127,203
Family $127,203
Miss. Natalia Farias, Fnp-Bc, FNP-BC
Family — Payments: $121,549
Family $121,549
Dr. Corrie Berk, Dnp, DNP
Family — Payments: $82,362
Family $82,362
Tina Copple, Aprn, APRN
Family — Payments: $67,667
Family $67,667
Kim Hinojosa, Fnp-C, FNP-C
Family — Payments: $56,155
Family $56,155
Roberta Romero, Fnp, FNP
Family — Payments: $23,128
Family $23,128